Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Litifilimab - Biogen

Next Previous
Drug Profile

Litifilimab - Biogen

Alternative Names: 24F4A; Anti-BDCA2 antibody - Biogen; BIIB-059

Latest Information Update: 14 Sep 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Biogen Idec
  • Developer Biogen
  • Class Monoclonal antibodies; Skin disorder therapies
  • Mechanism of Action Dendritic cell inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Cutaneous lupus erythematosus; Systemic lupus erythematosus

Most Recent Events

  • 06 Jun 2026 efficacy and adverse event data from a phase II/III AMETHYST trial in Cutaneous lupus erythematosus presented at the 27th Annual Congress of the European League Against Rheumatism (EULAR 2026)
  • 06 Jun 2026 Efficacy data from the phase-II LILAC trial in Lupus Erythematosus presented at the 27th Annual Congress of the European League Against Rheumatism (EULAR-2026)
  • 29 Mar 2026 Adverse events and efficacy data from the Part A portion of phase II/III AMETHYST trial in Cutaneous lupus erythematosus released by Biogen

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top